耐受性
小干扰RNA
化学
核糖
计算生物学
立体化学
组合化学
生物化学
核糖核酸
药理学
生物
基因
不利影响
酶
作者
Daniel O’Reilly,Raymond Furgal,Vignesh Hariharan,Clemens Lochmann,David Cooper,Dimas Echeverria,Anastasia Khvorova
出处
期刊:Nucleic Acid Therapeutics
[Mary Ann Liebert, Inc.]
日期:2025-05-26
卷期号:35 (3): 137-149
被引量:2
标识
DOI:10.1089/nat.2024.0077
摘要
Chemically modified short interfering RNAs (siRNAs) unequivocally represent a groundbreaking class of drugs. The deliberate chemical modification of the natural structure has been pivotal to their resounding success. Specific modifications at certain positions bolster their potency, safety, stability, and specificity. In clinical research, 2'-O-methyl and 2'-fluoro are the most used modifications. The effects of a wide range of chemical changes in fully modified siRNAs have not been thoroughly evaluated for tolerability. In this study, we utilized two sequences in a fully modified siRNA to systematically assess the tolerability of single nucleotide backbone and sugar modifications, including deoxyribonucleic acid, 2'-O-(2-methoxyethyl), locked nucleic acid, unlocked nucleic acid, mismatches, butane diol substitution, and butane diol insertion. We synthesized 522 siRNA variants and evaluated their efficacy in vitro. Our findings demonstrate that individual tolerability is significantly influenced by the modification's sequence, pattern, and position, with limited universal principles identifiable from this dataset. The efficacy results are probably driven by the thermodynamic balance defined by a combination of parameters. The framework presented here will serve as a reference dataset to facilitate the expansion of chemical diversity in therapeutic siRNAs.
科研通智能强力驱动
Strongly Powered by AbleSci AI